282 related articles for article (PubMed ID: 27646163)
1. Therapeutic potential of boswellic acids: a patent review (1990-2015).
Hussain H; Al-Harrasi A; Csuk R; Shamraiz U; Green IR; Ahmed I; Khan IA; Ali Z
Expert Opin Ther Pat; 2017 Jan; 27(1):81-90. PubMed ID: 27646163
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).
Hussain H; Green IR; Ali I; Khan IA; Ali Z; Al-Sadi AM; Ahmed I
Expert Opin Ther Pat; 2017 Sep; 27(9):1061-1072. PubMed ID: 28637397
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacins as Anticancer Agents: A Patent Review.
Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
[TBL] [Abstract][Full Text] [Related]
4. A patent review of two fruitful decades (1997-2016) of Isocoumarin research.
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Nov; 27(11):1267-1275. PubMed ID: 28621561
[TBL] [Abstract][Full Text] [Related]
5. Boswellic acids: privileged structures to develop lead compounds for anticancer drug discovery.
Hussain H; Ali I; Wang D; Hakkim FL; Westermann B; Rashan L; Ahmed I; Green IR
Expert Opin Drug Discov; 2021 Aug; 16(8):851-867. PubMed ID: 33650441
[No Abstract] [Full Text] [Related]
6. Therapeutic potential of glycyrrhetinic acids: a patent review (2010-2017).
Hussain H; Green IR; Shamraiz U; Saleem M; Badshah A; Abbas G; Rehman NU; Irshad M
Expert Opin Ther Pat; 2018 May; 28(5):383-398. PubMed ID: 29558289
[TBL] [Abstract][Full Text] [Related]
7. Indazole derivatives and their therapeutic applications: a patent review (2013-2017).
Denya I; Malan SF; Joubert J
Expert Opin Ther Pat; 2018 Jun; 28(6):441-453. PubMed ID: 29718740
[TBL] [Abstract][Full Text] [Related]
8. Usnic acid and its derivatives for pharmaceutical use: a patent review (2000-2017).
Luzina OA; Salakhutdinov NF
Expert Opin Ther Pat; 2018 Jun; 28(6):477-491. PubMed ID: 29718734
[TBL] [Abstract][Full Text] [Related]
9. Interference of boswellic acids with the ligand binding domain of the glucocorticoid receptor.
Scior T; Verhoff M; Gutierrez-Aztatzi I; Ammon HP; Laufer S; Werz O
J Chem Inf Model; 2014 Mar; 54(3):978-86. PubMed ID: 24512031
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in therapeutic applications of chalcones.
Katsori AM; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
[TBL] [Abstract][Full Text] [Related]
11. Boswellic Acids and Their Role in Chronic Inflammatory Diseases.
Ammon HP
Adv Exp Med Biol; 2016; 928():291-327. PubMed ID: 27671822
[TBL] [Abstract][Full Text] [Related]
12. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
13. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
14. Boswellic acids target the human immune system-modulating antimicrobial peptide LL-37.
Henkel A; Tausch L; Pillong M; Jauch J; Karas M; Schneider G; Werz O
Pharmacol Res; 2015 Dec; 102():53-60. PubMed ID: 26361729
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid and its derivatives: a patent review (2008-2013).
Csuk R
Expert Opin Ther Pat; 2014 Aug; 24(8):913-23. PubMed ID: 24909232
[TBL] [Abstract][Full Text] [Related]
16. A patent review of the therapeutic potential of isoflavones (2012-2016).
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Oct; 27(10):1135-1146. PubMed ID: 28586284
[TBL] [Abstract][Full Text] [Related]
17. Prospects of boswellic acids as potential pharmaceutics.
Du Z; Liu Z; Ning Z; Liu Y; Song Z; Wang C; Lu A
Planta Med; 2015 Mar; 81(4):259-71. PubMed ID: 25714728
[TBL] [Abstract][Full Text] [Related]
18. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
Tandon VK; Kumar S
Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
[TBL] [Abstract][Full Text] [Related]
19. Boswellic acids: biological actions and molecular targets.
Poeckel D; Werz O
Curr Med Chem; 2006; 13(28):3359-69. PubMed ID: 17168710
[TBL] [Abstract][Full Text] [Related]
20. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Salvador JAR; Leal AS; Valdeira AS; Gonçalves BMF; Alho DPS; Figueiredo SAC; Silvestre SM; Mendes VIS
Eur J Med Chem; 2017 Dec; 142():95-130. PubMed ID: 28754470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
